168 related articles for article (PubMed ID: 27150145)
1. Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine.
Nagata M; Nakajima M; Ishiwata Y; Takahashi Y; Takahashi H; Negishi K; Yasuhara M
Biol Pharm Bull; 2016; 39(5):754-61. PubMed ID: 27150145
[TBL] [Abstract][Full Text] [Related]
2. Clozapine-Induced Acute Hyperglycemia Is Accompanied with Elevated Serum Concentrations of Adrenaline and Glucagon in Rats.
Nagata M; Kimura Y; Ishiwata Y; Takahashi H; Yasuhara M
Biol Pharm Bull; 2018; 41(8):1286-1290. PubMed ID: 30068879
[TBL] [Abstract][Full Text] [Related]
3. Gatifloxacin-induced histamine release and hyperglycemia in rats.
Ishiwata Y; Yasuhara M
Eur J Pharmacol; 2010 Oct; 645(1-3):192-7. PubMed ID: 20674567
[TBL] [Abstract][Full Text] [Related]
4. Effect of levofloxacin on serum glucose concentration in rats.
Ishiwata Y; Itoga Y; Yasuhara M
Eur J Pharmacol; 2006 Dec; 551(1-3):168-74. PubMed ID: 17026994
[TBL] [Abstract][Full Text] [Related]
5. Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance.
Girault EM; Alkemade A; Foppen E; Ackermans MT; Fliers E; Kalsbeek A
PLoS One; 2012; 7(8):e43244. PubMed ID: 22905238
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration.
Chintoh AF; Mann SW; Lam L; Lam C; Cohn TA; Fletcher PJ; Nobrega JN; Giacca A; Remington G
J Clin Psychopharmacol; 2008 Oct; 28(5):494-9. PubMed ID: 18794643
[TBL] [Abstract][Full Text] [Related]
7. Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia.
Castellani LN; Peppler WT; Sutton CD; Whitfield J; Charron MJ; Wright DC
Psychoneuroendocrinology; 2017 Aug; 82():38-45. PubMed ID: 28500893
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-induced hyperglycemia: possible involvement of histaminergic, dopaminergic and adrenergic functions in the central nervous system.
Ikegami M; Ikeda H; Ohashi T; Kai M; Osada M; Kamei A; Kamei J
Neuroendocrinology; 2013; 98(3):224-32. PubMed ID: 24135197
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-induced changes in glucose metabolism are independent of the melanin-concentrating hormone system.
Girault EM; Toonen PW; Eggels L; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
Psychoneuroendocrinology; 2013 Nov; 38(11):2640-6. PubMed ID: 23856185
[TBL] [Abstract][Full Text] [Related]
10. Relative contribution of nervous system and hormones to hyperglycemia induced by thyrotropin-releasing hormone in fed rats.
Ishiguro T; Iguchi A; Kunoh Y; Goto M; Uemura K; Miura H; Nonogaki K; Sakamoto N
Neuroendocrinology; 1991 Jul; 54(1):1-6. PubMed ID: 1681438
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.
Girault EM; Guigas B; Alkemade A; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
Naunyn Schmiedebergs Arch Pharmacol; 2014 Feb; 387(2):185-95. PubMed ID: 24190543
[TBL] [Abstract][Full Text] [Related]
12. Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice.
Castellani LN; Peppler WT; Miotto PM; Bush N; Wright DC
Sci Rep; 2018 Jan; 8(1):772. PubMed ID: 29335597
[TBL] [Abstract][Full Text] [Related]
13. Rapidly developing hyperglycemia during treatment with olanzapine.
Kohen I; Gampel M; Reddy L; Manu P
Ann Pharmacother; 2008 Apr; 42(4):588-91. PubMed ID: 18364401
[TBL] [Abstract][Full Text] [Related]
14. Effects of moxifloxacin on serum glucose concentrations in rats.
Ishiwata Y; Takahashi Y; Nagata M; Yasuhara M
Biol Pharm Bull; 2013; 36(4):686-90. PubMed ID: 23358329
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the central hyperglycemic action of histamine in mice.
Nishibori M; Itoh Y; Oishi R; Saeki K
J Pharmacol Exp Ther; 1987 May; 241(2):582-6. PubMed ID: 3572814
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucagon, glucose, adrenaline and insulin infusion on blood glucose level in the common African toad (bufo regularis).
Oyebola DD; Ariwodola JO; Alada AR
Afr J Med Med Sci; 1998; 27(1-2):89-94. PubMed ID: 10456139
[TBL] [Abstract][Full Text] [Related]
18. Autonomic and endocrine participation in opioid peptide-induced hyperglycemia.
Appel NM; Track NS; Van Loon GR
J Auton Nerv Syst; 1987 Oct; 20(3):221-31. PubMed ID: 2826568
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.
Houseknecht KL; Robertson AS; Zavadoski W; Gibbs EM; Johnson DE; Rollema H
Neuropsychopharmacology; 2007 Feb; 32(2):289-97. PubMed ID: 17035934
[TBL] [Abstract][Full Text] [Related]
20. Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model.
Hahn MK; Chintoh A; Remington G; Teo C; Mann S; Arenovich T; Fletcher P; Lam L; Nobrega J; Guenette M; Cohn T; Giacca A
Eur Neuropsychopharmacol; 2014 Mar; 24(3):448-58. PubMed ID: 24001874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
